Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04754087 · ClinicalTrials.gov registry record · NA
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
A NA study of Osteoarthritis, Hip and Total Hip Arthroplasty, sponsored by Zimmer Biomet.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 11
- Study locations
NCT04754087: Recruiting NA study of Osteoarthritis, Hip and Total Hip Arthroplasty, sponsored by Zimmer Biomet.
NCT04754087 is a NA study of Osteoarthritis, Hip and Total Hip Arthroplasty that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 300 participants, below the 1,258-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (76% lower). The trial reports 11 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04754087, a NA study of Osteoarthritis, Hip and Total Hip Arthroplasty, is actively recruiting participants, sponsored by Zimmer Biomet.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 11
- Study locations
Study Summary
The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
Primary Outcome
Survivorship will be based on revision or intended revision of the study device (liner).
Conditions Studied
Interventions
- DEVICE Vivacit-E and Longevity (HXLPE) Liners
Study Locations (11)
Other
- Copenhagen University Hospital Hvidovre - Hvidovre
- Zuyderland Hospital - Geleen
- OCON Hengelo - Hengelo
- Skane University Hospital - Lund
Oregon
- Slocum Center for Orthopedics & Sports Medicine - Eugene
- Oregon Health and Science University - Portland
Colorado
- Colorado Joint Replacement - Denver
Indiana
- South Bend Orthopaedics - South Bend
North Carolina
- Duke University Medical Center - Durham
Utah
- University of Utah Health - Salt Lake City
UK
- The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Royal Bournemouth Hospital - Bournemouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-07-07 |
| Est. Completion | 2033-12-31 |
| Phase | NA |
What NCT04754087 shows while recruiting
NCT04754087 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,258-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (76% lower).
The record links to 8 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which Vivacit-E and Longevity (HXLPE) Liners is the first listed.
NCT04754087 lists 11 locations in 7 states (Other, Oregon, Colorado).
Frequently Asked Questions
What is clinical trial NCT04754087 about?
NCT04754087 is a clinical study titled "G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study". The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
What is the current status of trial NCT04754087?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-07-07. Estimated completion is 2033-12-31.
What conditions does trial NCT04754087 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Total Hip Arthroplasty, Avascular Necrosis of Hip, Degenerative Joint Disease of Hip, Rheumatoid Arthritis of Hip.
What interventions are being tested in trial NCT04754087?
The interventions under investigation include: Vivacit-E and Longevity (HXLPE) Liners (DEVICE).
Who is sponsoring clinical trial NCT04754087?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04754087 being conducted?
This trial has 11 study locations across Colorado, Indiana, North Carolina, Oregon, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04754087's enrollment target sits among peer trials
300 7th of 20 higher than 14 of 20 other Osteoarthritis, Hip trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Hip trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
RECRUITING · NA
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI